About KICancer network

The network is open to all scientists and students at Karolinska Institutet who have an interest or work with cancer. The network includes cancer researchers from all disciplines including clinical research, nursing sciences, epidemiology and basic science. At present this network has some 750 members from 135 research groups, distributed over twelve departments in four campuses and hospitals all over Stockholm. The network interacts with the Strategic Cancer Initiative at KI, StratCan.


Cancer makes up more than 30% of the research volume at KI, and is one of KIs two largest and most competitive research areas. In bibliometric rankings recent years KI cancer research has been listed as number 12 in the world and number one outside USA.

KICancer has been in operation since 2003.

KICancer has its mission from the KI Board of Research; primarily to catalyze KI-Cancer re­search by intergroup and interdepartmental  interactions, in particular translational research. Cancer research at the Karolinska is of highest international class in several focused areas. The existence of KICancer has con­tributed to many new collaborative initiatives between groups, depart­ments and disciplines, which make KI´s cancer research as a whole even more competitive.

The Health care and Research organizations have to carry out their missions hand in hand. Therefore we put efforts into intergrating KICancer with the health care organization. KICancer has been given the mission to develop a concept of Personalised Cancer Medicine (PCM) at KI together with the clinical units aiming for a Comprehensive Cancer Center (CCC).

KICancer acts by arranging physical and virtual meeting points to create a sense of community and network

  • annual KICancer retreat
  • eNewsletter
  • home page with links to members
  • KICancer seminars and focused workshops

KICancer is responsible for the FoTO-PhD program. The annual retreat invites all students and scientists for two days with international key note speakers and critically reviewed lectures and poster sessions presenting in-house work by the students.

Steering group


Professor, senior

Ingemar Ernberg

Organizational unit: Ingemar Ernberg group
E-mail: Ingemar.Ernberg@ki.se


Project Manager

Britt-Marie Bernhardson

Phone: +46-(0)72-167 89 11
Organizational unit: MMC/Innovative care
E-mail: Britt-Marie.Bernhardson@ki.se


Kamila Czene

Phone: +46-(0)8-524 861 44
Organizational unit: Department of Medical Epidemiology and Biostatistics (MEB), C8
E-mail: Kamila.Czene@ki.se


Dan Grander

Phone: +46-(0)8-517 762 62
Organizational unit: Research Group Grandér, Dan
E-mail: Dan.Grander@ki.se

Senior researcher

Maria Kasper

Phone: +46-(0)8-524 810 29
Organizational unit: Kasper
E-mail: maria.kasper@ki.se


Sonia Lain

Phone: +46-(0)8-524 846 03
Organizational unit: Sonia Lain group
E-mail: sonia.lain@ki.se


Catharina Larsson

Organizational unit: Research Group Larsson, Catharina
E-mail: Catharina.Larsson@ki.se

Professor/senior physician

Anna Martling

Phone: +46-(0)8-517 728 02
Organizational unit: Colorectal Surgery
E-mail: Anna.Martling@ki.se

Senior researcher

Maria Shoshan

Phone: +46-(0)8-517 754 60
Organizational unit: Research Group Shoshan, Maria
E-mail: Mimmi.Shoshan@ki.se

Professor, senior

Boris Zhivotovsky

Organizational unit: Toxicology
E-mail: Boris.Zhivotovsky@ki.se


The Strategic Reseach Program in Cancer (StratCan) at Karolinska Institutet combines cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines. The overall goal is to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society. The StratCan research environment acts a meeting point for the leading cancer research at KI.The environment has since its start increased in size and now also includes a number of junior scientists which have been awarded various forms of career-supporting grants. 

Advisory Board (International)

  • Prof. Harald zur Hausen, Heidelberg
  • Prof Mina Bissell, Lawrence Berkeley, California
  • Prof. Douglas Hanahan, UCSF
  • Prof David Livingston, Dana-Farber & Harvard Cancer Center, Boston
Cancer and OncologyNetwork